N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists

Details for Australian Patent Application No. 2002338334 (hide)

International Classifications

Event Publications

20 February 2003 Complete Application Filed

Priority application(s): 60/281,166 03.04.01 US

10 April 2003 Application Open to Public Inspection

Published as AU-B-2002338334

14 August 2008 Application Accepted

Published as AU-B-2002338334

18 September 2008 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002338334, under INID(72), correct the co-inventors names to McCauley, James A. and McIntyre, Charles J.

9 October 2008 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002338334, under INID(72), correct the co inventor name McCauley, John A.

11 December 2008 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.